Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave
Read More
iShares U.S. Pharmaceuticals ETF
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the
Read More
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive
Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |
Read More
Stocks making the biggest moves midday: IBM, AMD, Dillard’s, Novo Nordisk, Keysight
These are the stocks posting the largest moves in midday trading. This article was originally published by a Cnbc.com. Read
Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.
Read More
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino’s Pizza and more
Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said
Read More